TB-500 in Australia

TB-500 is a staple of tissue-repair and recovery research, frequently studied alongside BPC-157. This page covers what it is, the research areas it appears in, and how to source it with proper documentation from Australian stock.

What is TB-500?

TB-500 is a synthetic version of the active region of thymosin beta-4, a naturally occurring peptide involved in actin regulation and cell movement. It's widely referenced in the recovery and tissue-repair research literature.

The distinction between TB-500 and thymosin beta-4 itself is worth being precise about, because the two names are often used interchangeably and they are not the same molecule. Thymosin beta-4 is a 43-amino-acid protein found naturally throughout the body. TB-500 is a short synthetic fragment corresponding to the active binding region of that protein — roughly seven amino acids — rather than the full-length sequence. Suppliers listing "TB-500" and "thymosin beta-4" as the same item are being loose with terminology.

That active region is the part of the parent protein responsible for binding actin, which is the mechanism the compound is defined by in published work. Because the fragment is short and unmodified, it is straightforward to synthesise and inexpensive relative to the full-length protein — which is why the fragment, not the intact protein, is what appears in most laboratory work.

Research areas

In the scientific literature, TB-500 is studied in relation to:

• Muscle and tendon recovery research
• Flexibility and connective-tissue repair research
• Cell-migration and actin-regulation research
• Angiogenesis (blood-vessel formation) and healing research
• Cytoskeletal organisation and cell-motility research models

These describe fields of scientific study — they are not claims about effects in humans. Nothing on this page should be read as a statement about what the compound does in a person, and NextGen Peptides supplies it strictly for laboratory and in-vitro research use.

Actin regulation is the thread running through all of them. Actin is one of the primary structural proteins of the cell's cytoskeleton, and its assembly and disassembly is what allows cells to change shape and migrate. Because cell migration is a component of most tissue-repair models, a compound characterised by actin binding shows up across research areas that look unrelated on the surface — muscular, connective-tissue and vascular models are frequently examining the same underlying mechanism.

TB-500 and BPC-157

The two are frequently studied together in recovery research because they act through different mechanisms — TB-500 on actin and cell migration, BPC-157 on angiogenesis and growth-factor pathways. Researchers comparing or combining tissue-repair compounds often look at both.

• TB-500 — a synthetic fragment of thymosin beta-4, characterised by actin binding and associated in the literature with cell-migration pathways.
• BPC-157 — a 15-amino-acid fragment of a gastric protein, associated instead with angiogenesis and growth-factor signalling.

The reason they are paired so often in comparative work is precisely that they are not substitutes for one another: two different pathways, overlapping research areas. Our BPC-157 vs TB-500 guide works through the structural and pathway differences in full.

Storage & handling

Supplied as a lyophilised (freeze-dried) powder. Store at −20°C; reconstitute with bacteriostatic water and refrigerate once mixed. See our full guide to storing and reconstituting research peptides.

The points that determine whether a vial survives its working life:

• Before reconstitution. Lyophilised powder is stable and forgiving. At −20°C and out of light it keeps long-term, and it tolerates refrigeration and short periods at room temperature in transit — which is why vials ship without cold chain and arrive intact.
• Choice of diluent. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which is what allows a vial to be drawn from repeatedly over weeks. Sterile water has no preservative and is single-use.
• Technique. Run the diluent slowly down the inside wall of the vial rather than onto the powder cake, then swirl gently until dissolved — never shake. Foaming is the visible sign the molecule is being mechanically denatured.
• After reconstitution. Refrigerate at 2–8°C, generally good for around four weeks. Never refreeze — ice crystals forming through a freeze–thaw cycle physically damage peptide structure.
• Steady beats convenient. Keep vials boxed and towards the back of the fridge, not the door. Repeated warming and cooling does more damage than one stable temperature.

Concentration is set by how much diluent you add, not by the vial itself — a 10mg vial reconstituted with 1mL gives 10mg/mL, and with 2mL gives 5mg/mL. Our peptide reconstitution calculator works out the resulting concentration and draw volume for any combination.

What the Certificate of Analysis tells you

A Certificate of Analysis is the only objective evidence that what is in the vial matches the label. Two tests carry the weight:

• RP-HPLC establishes purity — it separates the sample into components and reports the target peptide as a percentage of the total. Research-grade material is typically ≥98%.
• LC-MS establishes identity — it measures molecular mass and confirms the compound is the peptide named on the label, not a different molecule of similar purity.

Identity testing matters more than usual here, given how routinely TB-500 and full-length thymosin beta-4 are conflated in listings. Purity alone cannot distinguish them; molecular mass can. A complete certificate also carries a batch number you can match against the vial, plus a test date. Certificates are published in our CoA library; our guide to reading a peptide CoA walks through a real one line by line, and how peptide purity is tested covers the methods themselves.

Sourcing TB-500 in Australia

We hold TB-500 in Australian stock, dispatched same or next business day when ordered before the daily cut-off. Every batch is independently third-party tested for purity (RP-HPLC) and identity (LC-MS), with the Certificate of Analysis published for you to read before ordering.

Local stock changes the practical picture. Orders of research chemicals shipped into Australia from overseas carry a real risk of being held or refused at the border, and even when they clear, two-to-four-week transit is normal — with the material outside controlled storage for that entire period. Domestic dispatch removes both problems: orders leave Melbourne, arrive inside the normal domestic post window, and are tracked the whole way in discreet, unmarked packaging. Full terms are on our shipping page.

When comparing suppliers the questions stay the same: is there a published CoA, does its batch number match the vial, does it cover identity as well as purity, and is the stock genuinely held in Australia rather than drop-shipped from overseas after you pay? Our guide to buying research peptides in Australia covers what to check. Laboratories and clinics ordering at volume can see wholesale and bulk supply.

Common questions about TB-500

What is TB-500?
A synthetic version of the active region of thymosin beta-4, a natural peptide involved in actin regulation and cell movement — widely referenced in tissue-repair research. Supplied for laboratory research use only.

What research areas is TB-500 studied in?
Muscle and tendon recovery, flexibility and connective-tissue repair, cell migration, and angiogenesis research. These are fields of study, not effects in humans.

How is TB-500 different from BPC-157?
TB-500 is studied mainly through actin regulation and cell migration; BPC-157 through angiogenesis and growth-factor signalling. Different mechanisms — see our full comparison.

Is TB-500 tested, and does it come with a CoA?
Yes — independently tested for purity (RP-HPLC) and identity (LC-MS), with the Certificate of Analysis published.

Is TB-500 held in Australian stock?
Yes — held locally and dispatched same or next business day for orders placed before the daily cut-off.

Is TB-500 the same as thymosin beta-4?
No. Thymosin beta-4 is a 43-amino-acid protein found naturally in the body. TB-500 is a short synthetic fragment corresponding to its active binding region, not the full-length sequence. Listings treating the two as identical are being loose with terminology.

What is TB-500's mechanism in the literature?
It is characterised by actin binding. Actin is a primary structural protein of the cell cytoskeleton, and its assembly and disassembly underlies cell migration — which is why the compound appears across research areas that look unrelated on the surface.

How long does a reconstituted vial last?
Generally around four weeks refrigerated at 2–8°C when reconstituted with bacteriostatic water. Unreconstituted powder at −20°C keeps far longer. Never refreeze a reconstituted solution.

What should I reconstitute it with?
Bacteriostatic water for multi-draw use — the 0.9% benzyl alcohol preservative is what makes repeated draws viable. Sterile water is single-use. Our reconstitution calculator works out the resulting concentration.

Why doesn't purity testing prove identity?
Because RP-HPLC measures how much of the sample is a single component, not which component it is. A pure sample of the wrong peptide still returns a high purity figure. LC-MS confirms molecular mass and therefore identity — particularly relevant here, given how often the fragment and the full-length protein are conflated.

Does it need cold-chain shipping?
No. Lyophilised powder is stable in transit. Orders ship from Melbourne in discreet, unmarked packaging with tracking — see shipping & delivery.

Legal status and intended use

TB-500 is supplied by NextGen Peptides strictly as a research chemical for laboratory and in-vitro use. It is not an approved therapeutic good in Australia, it is not supplied for human or veterinary consumption, and nothing on this site constitutes medical advice. Purchasers must be 18 or over.

The regulatory position around research peptides in Australia is worth understanding before ordering rather than assuming. We set out the framework — how the Therapeutic Goods Act treats unapproved goods, and where research-use supply sits within it — in our guide to the legal status of research peptides in Australia.

Related research

Explore related compounds held in Australian stock: BPC-157 and KPV.

Shop TB-500

Supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary consumption. The research areas listed describe fields of scientific study, not claims about effects in humans, and nothing here is medical advice.